Search Results

There are 8200903 results for: content related to: HCV treatment as prevention in prison: Key issues

  1. You have free access to this content
    The ethics of hepatitis C “treatment as prevention” among prisoners

    Hepatology

    Volume 61, Issue 1, January 2015, Page: 402, Michael H. Levy and Sarah Larney

    Version of Record online : 14 JUL 2014, DOI: 10.1002/hep.27195

  2. You have full text access to this OnlineOpen article
    HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

    Journal of Viral Hepatitis

    Volume 22, Issue 4, April 2015, Pages: 399–408, N. K. Martin, G. R. Foster, J. Vilar, S. Ryder, M. E. Cramp, F. Gordon, J. F. Dillon, N. Craine, H. Busse, A. Clements, S. J. Hutchinson, A. Ustianowski, M. Ramsay, D. J. Goldberg, W. Irving, V. Hope, D. De Angelis, M. Lyons, P. Vickerman and M. Hickman

    Version of Record online : 7 OCT 2014, DOI: 10.1111/jvh.12338

  3. Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?

    Addiction

    Volume 110, Issue 6, June 2015, Pages: 975–983, Anneke S. de Vos, Maria Prins and Mirjam E. E. Kretzschmar

    Version of Record online : 8 FEB 2015, DOI: 10.1111/add.12842

  4. Review article: treatment as prevention – targeting people who inject drugs as a pathway towards hepatitis C eradication

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 2, July 2016, Pages: 145–156, J. D. Leask and J. F. Dillon

    Version of Record online : 20 MAY 2016, DOI: 10.1111/apt.13673

  5. You have free access to this content
    Poster Session 4: Acute Liver Failure and Artificial Liver Support; Diagnostics, Epidemiology, and Natural History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1064A–1132A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28236

  6. You have full text access to this OnlineOpen article
    Eradication of hepatitis C infection: The importance of targeting people who inject drugs

    Hepatology

    Volume 59, Issue 2, February 2014, Pages: 366–369, Margaret Hellard, Joseph S. Doyle, Rachel Sacks-Davis, Alexander J. Thompson and Emma McBryde

    Version of Record online : 24 DEC 2013, DOI: 10.1002/hep.26623

  7. You have free access to this content
    HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms

    HIV Medicine

    Volume 15, Issue 10, November 2014, Pages: 621–624, CL Cooper and MB Klein

    Version of Record online : 6 MAY 2014, DOI: 10.1111/hiv.12161

  8. Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?

    Addiction

    Ilias Gountas, Vana Sypsa, Olga Anagnostou, Natasha Martin, Peter Vickerman, Evangelos Kafetzopoulos and Angelos Hatzakis

    Version of Record online : 17 FEB 2017, DOI: 10.1111/add.13764

  9. Psychiatric and Substance Use Disorders among Methadone Maintenance Patients with Chronic Hepatitis C Infection: Effects on Eligibility for Hepatitis C Treatment

    The American Journal on Addictions

    Volume 20, Issue 4, July-August 2011, Pages: 312–318, Steven L. Batki, Kelly M. Canfield and Robert Ploutz-Snyder

    Version of Record online : 31 MAY 2011, DOI: 10.1111/j.1521-0391.2011.00139.x

  10. You have full text access to this OnlineOpen article
    Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention

    Journal of Viral Hepatitis

    Volume 24, Issue 6, June 2017, Pages: 486–495, H. H. Ayoub and L. J. Abu-Raddad

    Version of Record online : 23 JAN 2017, DOI: 10.1111/jvh.12671

  11. Understanding decisions made about hepatitis C treatment by couples who inject drugs

    Journal of Viral Hepatitis

    Volume 23, Issue 2, February 2016, Pages: 89–95, C. Treloar, J. Rance, J. Bryant and S. Fraser

    Version of Record online : 25 AUG 2015, DOI: 10.1111/jvh.12451

  12. Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study

    Journal of Viral Hepatitis

    Volume 22, Issue 11, November 2015, Pages: 914–925, M. Alavi, M. Micallef, E. Fortier, A. J. Dunlop, A. C. Balcomb, C. A. Day, C. Treloar, N. Bath, P. S. Haber, G. J. Dore, J. Grebely and on behalf of the ETHOS Study Group

    Version of Record online : 21 MAY 2015, DOI: 10.1111/jvh.12415

  13. You have free access to this content
    Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)

    Journal of Viral Hepatitis

    Volume 21, Issue s1, May 2014, Pages: 1–4, G. J. Dore, J. Ward and M. Thursz

    Version of Record online : 8 APR 2014, DOI: 10.1111/jvh.12253

  14. You have full text access to this OnlineOpen article
    Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1598–1609, Natasha K. Martin, Peter Vickerman, Jason Grebely, Margaret Hellard, Sharon J. Hutchinson, Viviane D. Lima, Graham R. Foster, John F. Dillon, David J. Goldberg, Gregory J. Dore and Matthew Hickman

    Version of Record online : 26 AUG 2013, DOI: 10.1002/hep.26431

  15. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999–2011

    Journal of Viral Hepatitis

    Volume 21, Issue 3, March 2014, Pages: 198–207, J. Iversen, J. Grebely, L. Topp, H. Wand, G. Dore and L. Maher

    Version of Record online : 1 JUL 2013, DOI: 10.1111/jvh.12129

  16. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents

    Liver International

    Volume 34, Issue 8, September 2014, Pages: 1198–1206, Maryam Alavi, Jesse D. Raffa, Gregory D. Deans, Calvin Lai, Mel Krajden, Gregory J. Dore, Mark W. Tyndall and Jason Grebely

    Version of Record online : 20 NOV 2013, DOI: 10.1111/liv.12370

  17. Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue

    Journal of Viral Hepatitis

    Volume 21, Issue 12, December 2014, Pages: e167–e168, M. Hickman, N. Martin, P. Vickerman and S. Hutchinson

    Version of Record online : 29 SEP 2014, DOI: 10.1111/jvh.12340

  18. Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review

    Journal of Viral Hepatitis

    Volume 22, Issue 3, March 2015, Pages: 213–229, A. Cousien, V. C. Tran, S. Deuffic-Burban, M. Jauffret-Roustide, J.-S. Dhersin and Y. Yazdanpanah

    Version of Record online : 1 OCT 2014, DOI: 10.1111/jvh.12337

  19. Hepatitis C treatment as prevention among HIV-infected men who have sex with men: Feasible?

    Hepatology

    Volume 64, Issue 6, December 2016, Pages: 1834–1836, Gregory J. Dore

    Version of Record online : 6 OCT 2016, DOI: 10.1002/hep.28784

  20. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam

    Addiction

    Volume 107, Issue 3, March 2012, Pages: 614–623, Amy Matser, Anouk Urbanus, Ronald Geskus, Mirjam Kretzschmar, Maria Xiridou, Marcel Buster, Roel Coutinho and Maria Prins

    Version of Record online : 8 FEB 2012, DOI: 10.1111/j.1360-0443.2011.03654.x